Data as of Apr 17
| +0.08 / +2.33%|
The 1 analysts offering 12-month price forecasts for RXi Pharmaceuticals Corp have a median target of 13.50, with a high estimate of 13.50 and a low estimate of 13.50. The median estimate represents a +284.62% increase from the last price of 3.51.
The current consensus among 1 polled investment analysts is to Buy stock in RXi Pharmaceuticals Corp. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.